fda approvals in breast cancer and bladder cancer and phase iii data with larotrectinib
Published 6 years ago • 389 plays • Length 9:07
Download video MP4
Download video MP3
Similar videos
-
6:48
fda approval in prostate cancer, phase iii data in breast cancer, and more
-
7:21
fda approval in breast cancer, breakthrough designations in aml and bladder cancer, and more
-
10:25
fda approvals in gbm, biosimilar in breast cancer and gastric/gej cancer, and biomarker assay
-
8:05
fda approvals in nsclc, bladder cancer, and breast cancer, and death in car t-cell therapy trial
-
10:01
fda approvals in prostate cancer and esophageal cancer, and promising breast cancer data
-
9:27
fda approval in bladder cancer, breakthrough therapy designation in dlbcl, and more
-
10:18
fda approvals in bladder cancer and hodgkin lymphoma, breakthrough designation in aml, and more
-
8:51
fda approvals in nets, breast cancer, aml, a biosimilar, and more
-
8:30
fda approvals in bladder cancer, nsclc, aml, hcc, and a breakthrough designation in nsclc
-
7:27
fda approvals in prostate cancer and endometrial cancer, and priority review in urothelial cancer
-
11:13
fda approval in her2 early breast cancer, fast track designation in tnbc, and more
-
6:59
fda approval in nsclc, priority review in bladder cancer, mbcc highlights, and more
-
13:01
fda approvals in urothelial cancer and prostate cancer, priority review in crc, and more
-
11:00
fda approval in her2 breast cancer, priority review in nsclc, and more
-
6:58
fda approvals in nsclc and soft tissue sarcoma, priority review in bladder cancer, and more
-
10:55
fda approvals in cinv and her2 breast cancer, priority review in myelofibrosis, and more
-
8:43
fda approvals in bladder cancer and nsclc, and 2019 elcc highlights
-
18:36
breakthrough in bladder cancer: fda approval - enfortumab vedotin pelbrolizumab with dr.tom powles
-
10:55
fda approval in myeloma, label update in her2 breast cancer, and more
Clip.africa.com - Privacy-policy